Cancer Center News and Updates

1 - 10 of 248

FDA Approves Two Gene Therapies for Sickle Cell Disease

Published on

FDA Approves First CRISPR-Based Therapy for Sickle Cell Disease

The Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel) and LYFGENIA™ (lovotibeglogene autotemcel), the first two gene therapies for the treatment of sickle cell disease  in patients 12 years and older with recurrent vaso-occlusive crises (VOCs). 

Children’s Hospital of Philadelphia Receives Multi-Million Dollar Gift from Holveck Family to Support Groundbreaking Osteosarcoma Research

Published on

Children’s Hospital of Philadelphia (CHOP) has received a $6.4 million gift from the family of Connor Boyle, a Central Bucks East High School graduate who died at age 18 from osteosarcoma. This three-year gift, named The Connor Initiative: Precision Therapeutics for Osteosarcoma & Rare Cancers, will support cutting-edge research in osteosarcoma and other rare cancers.

CHOP Establishes Kelly and Chad Punchard Endowed Chair in Translational Sarcoma Research

Published on

Children’s Hospital of Philadelphia (CHOP) has announced the establishment of the Punchard Family Endowed Chair in Translational Sarcoma Research. Patrick J. Grohar, MD, PhD, an attending physician with the Cancer Center and the Director of Translational Research with the Center for Childhood Cancer Research at CHOP, has been named the inaugural chair holder.